STOCK TITAN

Sukumar Nagendran plans TSHA (TSHA) sale of 113,824 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TSHA insider files notice to sell common stock under Rule 144. A Form 144 was filed for the planned sale of 113,824 shares of TSHA common stock through broker Maxim Group LLC on Nasdaq, with an aggregate market value of $579,364.16. The filing notes 273,919,373 shares of TSHA common stock outstanding. The shares to be sold were acquired on 01/23/2026 via an RSU award from the issuer, vesting and settling in stock in exchange for the reporting person’s continued service.

The filer also reported prior TSHA stock sales in the past three months: 110,125 shares of common stock sold on 11/28/2025 for gross proceeds of $522,774.39, and 200,000 shares sold on 01/12/2026 for gross proceeds of $942,738.11. By signing the notice, the person for whose account the securities are to be sold represents that they do not know any undisclosed material adverse information about the issuer’s operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing for TSHA disclose?

The Form 144 discloses a planned sale of 113,824 shares of TSHA common stock under Rule 144. The shares are to be sold through Maxim Group LLC on the Nasdaq, with an indicated aggregate market value of 579,364.16.

How were the 113,824 TSHA shares being sold acquired?

The 113,824 shares of TSHA common stock were acquired on 01/23/2026 via an RSU award from the issuer. The award vested and was settled in stock, with consideration described as the reporting person’s continued service as an employee of the issuer.

How many TSHA shares are outstanding according to this notice?

The notice states that there are 273,919,373 shares of TSHA common stock outstanding as referenced in the securities information section.

What TSHA stock sales has the filer made in the past three months?

The filer reports two prior TSHA common stock sales in the past three months: 110,125 shares sold on 11/28/2025 for gross proceeds of 522,774.39, and 200,000 shares sold on 01/12/2026 for gross proceeds of 942,738.11.

What representation does the TSHA Form 144 filer make about inside information?

By signing the notice, the person for whose account the TSHA securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Which broker and exchange are involved in this planned TSHA stock sale?

The Form 144 lists Maxim Group LLC, located at 300 Park Avenue, 16th Floor, New York, NY 10022, as the broker for the sale of TSHA common stock on the Nasdaq exchange.

Taysha Gene Therapies, Inc.

NASDAQ:TSHA

TSHA Rankings

TSHA Latest News

TSHA Latest SEC Filings

TSHA Stock Data

1.39B
242.89M
11.15%
94.76%
14.95%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
DALLAS